- Are Fosamax and Reclast, Zometa the Same Thing?
- What Are Possible Side Effects of Fosamax?
- What Are Possible Side Effects of Reclast, Zometa?
- What Is Fosamax?
- What Is Reclast, Zometa?
- What Drugs Interact with Fosamax?
- What Drugs Interact with Reclast, Zometa?
- How Should Fosamax Be Taken?
- How Should Reclast, Zometa Be Taken?
Are Fosamax and Reclast, Zometa the Same Thing?
Fosamax (alendronate sodium) and Reclast, Zometa (zoledronic acid) are bisphosphonates used to treat and prevent osteoporosis, and to treat Paget's disease.
Reclast, Zometa is also used to treat high blood levels of calcium caused by cancer such as hypercalcemia of malignancy, multiple myeloma (a type of bone marrow cancer), or cancer that has spread from elsewhere in the body to the bone.
What Are Possible Side Effects of Fosamax?
Common side effects of Fosamax include:
- gas,
- constipation,
- heartburn,
- diarrhea,
- bloating,
- nausea,
- vomiting,
- stomach pain,
- joint pain or swelling,
- swelling in your hands or feet,
- dizziness,
- headache,
- eye pain,
- back pain, or
- weakness.
Serious side effects of Fosamax include:
- severe pain (joints, bone, muscle, jaw, back or heartburn),
- chest pain,
- difficulty swallowing,
- bloody stools,
- eye pain,
- skin blisters, and
- swelling of the face, tongue, or throat.
What Are Possible Side Effects of Reclast, Zometa?
Common side effects of Reclast, Zometa include:
- nausea,
- tiredness,
- flu-like symptoms (e.g., fever, chills, muscle/joint aches),
- cough,
- dizziness,
- headache,
- vision problems,
- diarrhea,
- constipation,
- joint or muscle pain, or
- injection site reactions (pain, redness, swelling).
What Is Fosamax?
Fosamax (alendronate sodium) is a bisphosphonate that is a specific inhibitor of osteoclast-mediated bone resorption used to both treat and prevent osteoporosis, and to treat Paget's disease.
What Is Reclast, Zometa?
Reclast, Zometa is a prescription medicine used to:
- Treat or prevent osteoporosis in women after menopause. Reclast, Zometa helps reduce the chance of having a hip or spinal fracture (break).
- Increase bone mass in men with osteoporosis.
- Treat or prevent osteoporosis in either men or women who will be taking corticosteroid medicines for at least one year.
- Treat certain men and women who have Paget's disease of the bone.
It is not known how long Reclast, Zometa works for the treatment and prevention of osteoporosis. You should see your doctor regularly to determine if Reclast, Zometa is still right for you.
Reclast, Zometa is not for use in children.
What Drugs Interact With Fosamax?
Fosamax may interact with aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs).
What Drugs Interact With Reclast, Zometa?
Reclast, Zometa may interact with different drugs. Reclast, Zometa may interact with diuretics (water pills), antibiotics, other medicines that can harm your kidneys, cancer medicines, or nonsteroidal anti-inflammatory drugs (NSAIDs).
How Should Fosamax Be Taken?
Fosamax is available in a tablet or oral liquid form. Each bottle of the oral solution contains 91.35 mg of alendronate monosodium salt trihydrate, which is the molar equivalent to 70 mg of the drug. The recommended initial dosage is one 70 mg molar equivalent tablet or oral liquid bottle once weekly or one 10 mg molar equivalent tablet per day. Fosamax must be taken at least one-half hour before the first food, beverage, or medication of the day with plain water only to avoid any reduction in gastrointestinal adsorption.
How Should Reclast, Zometa Be Taken?
- Your doctor will tell you how often you will receive Reclast, Zometa.
- Reclast, Zometa is given by infusion into your vein (intravenously). Your infusion should last at least 15 minutes.
- Before you receive Reclast, Zometa, drink at least 2 glasses of fluid (such as water) within a few hours as directed by your doctor.
- You may eat before your treatment with Reclast, Zometa.
- If you miss a dose of Reclast, Zometa, call your doctor or healthcare provider to schedule your next dose.
From 
Featured Centers
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
FDA. Fosamax Product Information.
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM241519.pdf
Novartis. Reclast Product Information.
https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/reclast.pdf?